Search research articles
Contact Us
Filters
Showing results (31-40 of 72) with videos related to
Page
of 8
Sort By:
Clinical Pharmacology and Therapeutics
|
September 7, 2017
Medications Recommended for Secondary Prevention After First Acute Coronary Syndrome: Effectiveness of Treatment Combinations in a Real-Life Setting
Julien Bezin, Olaf H Klungel, Régis Lassalle, et al.
Journal of the American Geriatrics Society
|
March 7, 2019
Treatment Modalities and Survival in Older Adults with Metastatic Colorectal Cancer in Real Life
Amandine Gouverneur, Julien Bezin, Jérémy Jové, et al.
Frontiers in Endocrinology
|
October 11, 2023
Statin treatment is not associated with an increased risk of adrenal insufficiency in real-world setting
Sandy Maumus-Robert, Ana Jarne-Munoz, Antoine Pariente, et al.
Cardiovascular Drugs and Therapy
|
August 26, 2021
Neurocognitive Disorders Associated with PCSK9 Inhibitors: a Pharmacovigilance Disproportionality Analysis
Amandine Gouverneur, Paola Sanchez-Pena, Gwenaelle Veyrac, et al.
Scientific Reports
|
March 3, 2026
PCSK9 inhibitors patterns of use in France from nationwide repeated cross-sectional and cohort studies
Allison Singier, Anne Bénard-Laribière, Ana Jarne-Munoz, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 25, 2025
Use and Potential Misuse of Glucagon-Like Peptide-1 Receptor Agonists in France: A Nationwide Cohort Study
Nathan du Soulier, Antoine Pariente, Julien Bezin, et al.
Pharmacological Research
|
August 10, 2016
Pharmacological treatments of cardiovascular diseases: Evidence from real-life studies
Francesco Salvo, Julien Bezin, Pauline Bosco-Levy, et al.
Journal of Women'S Health (2002)
|
November 18, 2025
Sex Differences in the Use and Discontinuation of Recommended Drugs in Secondary Ischemic Stroke Prevention: A Regional Registry-Based Analysis
Julia Perrier, Sandrine Domecq, Emilie Lesaine, et al.
Fundamental & Clinical Pharmacology
|
March 17, 2025
Second primary cancers and hormonal therapies for prostate cancer: A nested case-control study
Lucie-Marie Scailteux, Julien Bezin, Marion Gundelwein, et al.
Frontiers in Pharmacology
|
April 11, 2019
Risk of Drug-Drug Interactions in Out-Hospital Drug Dispensings in France: Results From the DRUG-Drug Interaction Prevalence Study
Louis Létinier, Sébastien Cossin, Yohann Mansiaux, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 72) with videos related to
Sort By:
Page
of 8
Clinical Pharmacology and Therapeutics
|
September 7, 2017
Medications Recommended for Secondary Prevention After First Acute Coronary Syndrome: Effectiveness of Treatment Combinations in a Real-Life Setting
Julien Bezin, Olaf H Klungel, Régis Lassalle, et al.
Journal of the American Geriatrics Society
|
March 7, 2019
Treatment Modalities and Survival in Older Adults with Metastatic Colorectal Cancer in Real Life
Amandine Gouverneur, Julien Bezin, Jérémy Jové, et al.
Frontiers in Endocrinology
|
October 11, 2023
Statin treatment is not associated with an increased risk of adrenal insufficiency in real-world setting
Sandy Maumus-Robert, Ana Jarne-Munoz, Antoine Pariente, et al.
Cardiovascular Drugs and Therapy
|
August 26, 2021
Neurocognitive Disorders Associated with PCSK9 Inhibitors: a Pharmacovigilance Disproportionality Analysis
Amandine Gouverneur, Paola Sanchez-Pena, Gwenaelle Veyrac, et al.
Scientific Reports
|
March 3, 2026
PCSK9 inhibitors patterns of use in France from nationwide repeated cross-sectional and cohort studies
Allison Singier, Anne Bénard-Laribière, Ana Jarne-Munoz, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 25, 2025
Use and Potential Misuse of Glucagon-Like Peptide-1 Receptor Agonists in France: A Nationwide Cohort Study
Nathan du Soulier, Antoine Pariente, Julien Bezin, et al.
Pharmacological Research
|
August 10, 2016
Pharmacological treatments of cardiovascular diseases: Evidence from real-life studies
Francesco Salvo, Julien Bezin, Pauline Bosco-Levy, et al.
Journal of Women'S Health (2002)
|
November 18, 2025
Sex Differences in the Use and Discontinuation of Recommended Drugs in Secondary Ischemic Stroke Prevention: A Regional Registry-Based Analysis
Julia Perrier, Sandrine Domecq, Emilie Lesaine, et al.
Fundamental & Clinical Pharmacology
|
March 17, 2025
Second primary cancers and hormonal therapies for prostate cancer: A nested case-control study
Lucie-Marie Scailteux, Julien Bezin, Marion Gundelwein, et al.
Frontiers in Pharmacology
|
April 11, 2019
Risk of Drug-Drug Interactions in Out-Hospital Drug Dispensings in France: Results From the DRUG-Drug Interaction Prevalence Study
Louis Létinier, Sébastien Cossin, Yohann Mansiaux, et al.
Page
of 8